Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem
Zozina V. I., Covantev S., Goroshko O. A., Krasnykh L. M., Kukes V. G.
Current Cardiology Reviews
Vol.14, Issue3, P. 164-174
Опубликовано: 2018
Тип ресурса: Обзор
DOI:10.2174/1573403X14666180416115428
Аннотация:
The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years, it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation. © 2018 Bentham Science Publishers.
Ключевые слова:
Cardiac procedures and resuscitation; Cardiac toxicity; Cardiomyopathies; Coenzyme Q10; Dyslipidemia; Heart failure; Hypertension; Ischemic heart disease; Metabolic syndrome; Myocardial infarction; Obesity; Type 2 diabetes mellitus; Viral myocarditis
ubidecarenone; ubidecarenone; ubiquinone; cardiomyopathy; cardiotoxicity; cardiovascular disease; dyslipidemia; heart arrest; heart arrhythmia; heart failure; heart infarction; heart surgery; human; hypertension; ischemic heart disease; metabolic disorder; metabolic syndrome X; non insulin dependent diabetes mellitus; nonhuman; obesity; percutaneous coronary intervention; resuscitation; Review; virus myocarditis; analogs and derivatives; cardiovascular disease; pathology; Cardiovascular Diseases; Humans; Metabolic Syndrome; Ubiquinone
Язык текста: Английский
ISSN: 1573-403X
Zozina V. I. Vladlena Igorevna 1993-
Covantev S.
Goroshko O. A.
Krasnykh L. M.
Kukes V. G. Vladimir Grigoryevich 1934-
Зозина В. И. Владлена Игоревна 1993-
Cовантев С.
Горошко О. А.
Краснyх Л. М.
Кукес В. Г. Владимир Григорьевич 1934-
Coenzyme Q10 in cardiovascular and metabolic diseases: Current state of the problem
Текст визуальный непосредственный
Current Cardiology Reviews
Vol.14, Issue3 P. 164-174
2018
Обзор
Cardiac procedures and resuscitation Cardiac toxicity Cardiomyopathies Coenzyme Q10 Dyslipidemia Heart failure Hypertension Ischemic heart disease Metabolic syndrome Myocardial infarction Obesity Type 2 diabetes mellitus Viral myocarditis
ubidecarenone ubidecarenone ubiquinone cardiomyopathy cardiotoxicity cardiovascular disease dyslipidemia heart arrest heart arrhythmia heart failure heart infarction heart surgery human hypertension ischemic heart disease metabolic disorder metabolic syndrome X non insulin dependent diabetes mellitus nonhuman obesity percutaneous coronary intervention resuscitation Review virus myocarditis analogs and derivatives cardiovascular disease pathology Cardiovascular Diseases Humans Metabolic Syndrome Ubiquinone
The burden of cardiovascular and metabolic diseases is increasing with every year. Although the management of these conditions has improved greatly over the years, it is still far from perfect. With all of this in mind, there is a need for new methods of prophylaxis and treatment. Coenzyme Q10 (CoQ10) is an essential compound of the human body. There is growing evidence that CoQ10 is tightly linked to cardiometabolic disorders. Its supplementation can be useful in a variety of chronic and acute disorders. This review analyses the role of CoQ10 in hypertension, ischemic heart disease, myocardial infarction, heart failure, viral myocarditis, cardiomyopathies, cardiac toxicity, dyslipidemia, obesity, type 2 diabetes mellitus, metabolic syndrome, cardiac procedures and resuscitation. © 2018 Bentham Science Publishers.